Skip to content

The randomized controlled study for the application of using methylene blue dye to identify sentinel lymph nodes in early stage breast cancer patients

The randomized controlled study for the application of using methylene blue dye to identify sentinel lymph nodes in early stage breast cancer patients

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022745
Enrollment
Unknown
Registered
2019-04-24
Start date
2019-05-01
Completion date
Unknown
Last updated
2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

group 1:Methylene blue is injected into the subareolar area.
group 2:Methylene blue is injected into the sites around the tumor.

Sponsors

Department of Breast Surgery in the Second Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: All participants are 18-80 years old women diagnosed with early breast cancer and sign the informed consent.

Exclusion criteria

Exclusion criteria: Pregnancy breast cancer, inflammatory breast cancer, occult breast cancer, previous history of breast surgery or sentinel lymph node puncture, skin ulceration of the breast, hypersensitivity to MB, people who have liver, heart or kidney failure, people suffer from asthma, people who have serious immune system disease.

Design outcomes

Primary

MeasureTime frame
Number of stained and fixed sentinel nodes;The number of successful mappings;Time for sentinel node staining and fixation;

Secondary

MeasureTime frame
The tumor size of the patients;

Countries

China

Contacts

Public ContactZhao Haidong
1571087392@qq.com+86 17709872228

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026